<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="paperszoo1\PMC4154657\results\search\disease\results.xml">
  <result pre="was originally developed as a safe and effective vaccine against" exact="smallpox" post="by employing serial passages in primary chicken embryo cells"/>
  <result pre="to what is achieved during a productive infection with replicating" exact="vaccinia virus" post="vectors [29] and makes MVA an attractive platform for"/>
  <result pre="as calculated with the KÃ¤rber method [31]. The highly attenuated" exact="vaccinia virus" post="(VACV) strain MVA (clonal isolate F6, CEF passage 584)"/>
  <result pre="pIIIRedH5 and placed under the transcriptional control of the modified" exact="vaccinia virus" post="early/late promoter PmH5 [34]. Recombinant MVA expressing 6KE1, E3E2,"/>
  <result pre="the reciprocal of the highest serum dilution still giving 100%" exact="suppression" post="of cpe. Determination of viral load In order to"/>
  <result pre="4ParolaP, de LamballerieX, JourdanJ, RoveryC, VaillantV, et al. (2006) Novel" exact="chikungunya" post="virus variant in travelers returning from Indian Ocean islands."/>
  <result pre="genotype, India. Emerg Infect Dis12: 1580â€&quot;1583.17176577 7RaviV (2006) Re-emergence of" exact="chikungunya" post="virus in India. Indian J Med Microbiol24: 83â€&quot;84.16687855 8PialouxG,"/>
  <result pre="319â€&quot;327.17448935 9TsetsarkinKA, VanlandinghamDL, McGeeCE, HiggsS (2007) A single mutation in" exact="chikungunya" post="virus affects vector specificity and epidemic potential. PLoS Pathog3:"/>
  <result pre="PoubeauP, StaikowskyF, LoryM, Le MoullecN, et al. (2007) Outbreak of" exact="chikungunya" post="on Reunion Island: early clinical and laboratory features in"/>
  <result pre="JossaumeA, GouixA, CotteL, et al. (2008) Persistent arthralgia associated with" exact="chikungunya" post="virus: a study of 88 adult patients on reunion"/>
  <result pre="Dis203: 149â€&quot;157.21288813 13HiggsS, ZieglerSA (2010) A nonhuman primate model of" exact="chikungunya" post="disease. J Clin Invest120: 657â€&quot;660.20179348 14SchilteC, StaikovskyF, CoudercT, MadecY,"/>
  <result pre="SimonF, GrandadamM, MichelR, TolouH, et al. (2008) Clinical burden of" exact="chikungunya" post="virus infection. Lancet Infect Dis8: 2â€&quot;3.18156079 16GerardinP, FianuA, MalvyD,"/>
  <result pre="ShastriP, BandyopadhyayT, ParmarJ, RamaniKV (2008) Increased mortality rate associated with" exact="chikungunya" post="epidemic, Ahmedabad, India. Emerg Infect Dis14: 412â€&quot;415.18325255 18RenaultP, JosseranL,"/>
  <result pre="(2003) Vaccinia vectors as candidate vaccines: the development of modified" exact="vaccinia virus" post="Ankara for antigen delivery. Curr Drug Targets Infect Disord3:"/>
  <result pre="Targets Infect Disord3: 263â€&quot;271.14529359 26MayrA, MunzE (1964) [Changes in the" exact="vaccinia virus" post="through continuing passages in chick embryo fibroblast cultures] Veranderung"/>
  <result pre="WyattLS, BenninkJR, HirschVM, et al. (1996) Host range restricted, non-replicating" exact="vaccinia virus" post="vectors as vaccine candidates. Adv Exp Med Biol397: 7â€&quot;13.8718576"/>
  <result pre="from the host range-restricted and highly attenuated MVA strain of" exact="vaccinia virus" post="stimulates protective immunity in mice to influenza virus. Vaccine12:"/>
  <result pre="strain of vaccinia virus stimulates protective immunity in mice to" exact="influenza" post="virus. Vaccine12: 1032â€&quot;1040.7975844 30ScholteFEM, TasA, MartinaBEE, CordioliP, NarayananK, et"/>
  <result pre="(2011) Probing the attenuation and protective efficacy of a candidate" exact="chikungunya" post="virus vaccine in mice with compromised interferon (IFN) signaling."/>
  <result pre="39WyattLS, ShorsST, MurphyBR, MossB (1996) Development of a replication-deficient recombinant" exact="vaccinia virus" post="vaccine effective against parainfluenza virus 3 infection in an"/>
  <result pre="et al. (2009) Elucidating and minimizing the loss by recombinant" exact="vaccinia virus" post="of human immunodeficiency virus gene expression resulting from spontaneous"/>
  <result pre="41HarropR, DruryN, ShinglerW, ChikotiP, RedchenkoI, et al. (2008) Vaccination of" exact="colorectal cancer" post="patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and"/>
  <result pre="DruryN, ShinglerW, ChikotiP, RedchenkoI, et al. (2008) Vaccination of colorectal" exact="cancer" post="patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and"/>
  <result pre="of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against" exact="chikungunya" post="virus. Vaccine30: 6142â€&quot;6149.22884660 46HarrisonVR, EckelsKH, BartelloniPJ, HamptonC (1971) Production"/>
  <result pre="J Immunol107: 643â€&quot;647.4999088 47NakaoE, HottaS (1973) Immunogenicity of purified, inactivated" exact="chikungunya" post="virus in monkeys. Bull World Health Organ48: 559â€&quot;562.4204490 48TiwariM,"/>
  <result pre="al. (2000) Phase II safety and immunogenicity study of live" exact="chikungunya" post="virus vaccine TSI-GSD-218. Am J Trop Med Hyg62: 681â€&quot;685.11304054"/>
  <result pre="681â€&quot;685.11304054 53PlanteK, WangE, PartidosCD, WegerJ, GorchakovR, et al. (2011) Novel" exact="chikungunya" post="vaccine candidate with an IRES-based attenuation and host range"/>
  <result pre="BaoH, KawalekarOU, FagoneP, et al. (2011) A DNA vaccine against" exact="chikungunya" post="virus is protective in mice and induces neutralizing antibodies"/>
  <result pre="WoraratanadharmJ, GardnerJ, et al. (2011) A complex adenovirus vaccine against" exact="chikungunya" post="virus provides complete protection against viraemia and arthritis. Vaccine29:"/>
 </snippets>
</snippetsTree>
